American and Israeli researchers get closer, along with the potential for investment and commercialization as $6 million from the Israel-U.S. Binational Industrial Research and Development…
In a deal worth nearly $1 billion if all milestones are met, one of the world’s largest biotech companies, Cambridge, MA-based Biogen Inc. (Nasdaq: BIIB) licensed…
The Immuno-NeuroPsychiatry Network of the European College of Neuropsychopharmacology recently led what the group claims is the largest systematic review and meta-analysis to date on…
Lung cancer survivors face a myriad of challenges, including severe neuropathic pain such as numbness, tingling pins-and-needles type sensations, sensitivity to touch as well as…
Hoag, a nonprofit, regional health care delivery network in Orange County, California, recently announced that the Pickup Family Neurosciences Institute initiated a clinical trial for…
Mental health and substance abuse compounds at crisis proportions in cities across the United States. From the West Coast to the East Coast and in…
A fourth-year undergraduate, and Latina, from the University of California, Irvine (UCI), made the selection for the prestigious Minority Access to Research Careers (MARC) Program,…
What if it was the case that sepsis and meningitis, types of severe infections, could contribute to the unfolding dynamics that ultimately lead to neurodegenerative…
A chemical compound found in cannabis, cannabidiol doesn’t contain the psychoactive substance known to give people the “high” associated with marijuana. Already, in the United States,…
The U.S. Food and Drug Administration (FDA) approved the first new drug for Alzheimer’s disease since 2003. Known as Aduhelm, this was big news, triggering…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
